China Pharma Holdings
CPHI
6 hedge funds and large institutions have $422K invested in China Pharma Holdings in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more capital invested
Capital invested by funds: $420K → $422K (+$2K)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
25% less funds holding
Funds holding: 8 → 6 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$6.99K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.01K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FWSM
First Wilshire Securities Management
Pasadena,
California
|
-$45K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$4K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$3K |
| 4 |
Renaissance Technologies
New York
|
-$1.28K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAM
1
Pope Asset Management
Memphis,
Tennessee
| $357K | – | – | – |
|
|
GA
2
Glenhill Advisors
New York
| $34K | – | – | – |
|
|
3
Renaissance Technologies
New York
| $16K | -$1.28K | -17 | -8% |
|
|
4
Goldman Sachs
New York
| $8K | +$6.99K | +93 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $5K | +$3.01K | +40 | +211% |
|
|
PCM
6
Parsons Capital Management
Providence,
Rhode Island
| $2K | – | – | – |
|
|
FWSM
7
First Wilshire Securities Management
Pasadena,
California
| – | -$45K | -573 | Closed |
|
|
8
Citadel Advisors
Miami,
Florida
| – | -$4K | -54 | Closed |
|
|
VKH
9
Virtu KCG Holdings
New York
| – | -$3K | -40 | Closed |
|
CPHI Hedge Fund Activity: Q1 2016 in Review
6 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q1 2016, worth a combined $422K — up 0.48% from $420K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CPHI and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $6.99K. The largest seller was First Wilshire Securities Management, exiting entirely with an estimated $45K sold.
- 6 institutional investors held China Pharma Holdings (CPHI) as of Q1 2016, down from 8 in Q4 2015.
- Funds reported $422K of China Pharma Holdings stock for Q1 2016, up 0.48% quarter-over-quarter.
- 1 fund opened new China Pharma Holdings positions in Q1 2016 and 3 closed out, a net change of -2 holders.
- The largest China Pharma Holdings buyer in Q1 2016 was Goldman Sachs, an estimated $6.99K added.
- The largest China Pharma Holdings seller in Q1 2016 was First Wilshire Securities Management, an estimated $45K sold.
Based on aggregated 13F filings for Q1 2016.